消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 ACG临床指南：特异性药物性肝损伤的诊断和管理

2021-05-01 美国胃肠病学院 Am J Gastroenterol

药物性肝损伤

本文主要针对特异性药物性肝损伤的诊断和管理提供指导建议。

中文标题：

2021 ACG临床指南：特异性药物性肝损伤的诊断和管理

英文标题：

ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

发布机构：

美国胃肠病学院

发布日期：

2021-05-01

简要介绍：

2021年5月，美国胃肠病学院(ACG)发布了特异性药物性肝损伤的诊断和管理指南，特异性药物性肝损伤（DILI）在消化科和肝病科比较常见，DILI可有多种表现，从肝脏生化检查的无症状升高到肝细胞或胆汁淤积性黄疸、肝衰竭或慢性肝炎等。本文主要针对特异性药物性肝损伤的诊断和管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ACG临床指南：特异性药物性肝损伤的诊断和管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8e79d1c0022a344f, title=2021 ACG临床指南：特异性药物性肝损伤的诊断和管理, enTitle=ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury, guiderFrom=Am J Gastroenterol, authorId=0, author=, summary=本文主要针对特异性药物性肝损伤的诊断和管理提供指导建议。, cover=https://img.medsci.cn/20211029/1635484892599_5579292.png, journalId=0, articlesId=null, associationId=269, associationName=美国胃肠病学院, associationIntro=美国胃肠病学院（ACG）是公认的胃肠专业教育及大众消化道疾病的领导者。The American Journal of Gastroenterology（AJG）为该学会的官方期刊。, copyright=0, guiderPublishedTime=Sat May 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年5月，美国胃肠病学院(ACG)发布了特异性药物性肝损伤的诊断和管理指南，特异性药物性肝损伤（DILI）在消化科和肝病科比较常见，DILI可有多种表现，从肝脏生化检查的无症状升高到肝细胞或胆汁淤积性黄疸、肝衰竭或慢性肝炎等。本文主要针对特异性药物性肝损伤的诊断和管理提供指导建议。</span></p>, tagList=[TagDto(tagId=605, tagName=药物性肝损伤)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=605, guiderKeyword=药物性肝损伤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1712, appHits=130, showAppHits=0, pcHits=388, showPcHits=1582, likes=0, shares=11, comments=4, approvalStatus=1, publishedTime=Sat Oct 30 21:30:38 CST 2021, publishedTimeString=2021-05-01, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Oct 29 13:25:15 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 18:56:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ACG临床指南：特异性药物性肝损伤的诊断和管理.pdf)])
2021 ACG临床指南：特异性药物性肝损伤的诊断和管理.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080940, encodeId=00d510809407b, content=每一个话题都参与, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77394750416, createdName=miniio110, createdTime=Thu Dec 16 23:23:56 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070121, encodeId=c43410e0121a1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Sun Nov 14 12:06:11 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068306, encodeId=c2d31068306a4, content=学习了，🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Mon Nov 08 22:52:05 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-12-16 miniio110

    每一个话题都参与

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080940, encodeId=00d510809407b, content=每一个话题都参与, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77394750416, createdName=miniio110, createdTime=Thu Dec 16 23:23:56 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070121, encodeId=c43410e0121a1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Sun Nov 14 12:06:11 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068306, encodeId=c2d31068306a4, content=学习了，🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Mon Nov 08 22:52:05 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-14 ms9000001618803930

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080940, encodeId=00d510809407b, content=每一个话题都参与, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77394750416, createdName=miniio110, createdTime=Thu Dec 16 23:23:56 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070121, encodeId=c43410e0121a1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Sun Nov 14 12:06:11 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068306, encodeId=c2d31068306a4, content=学习了，🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Mon Nov 08 22:52:05 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-08 1482963am12暂无昵称

    学习了，🙏

    0

相关指南

2021 APASL共识指南：药物性肝损伤

亚太肝脏研究学会(APASL,Asian-Pacific Association for the Study of the Liver) · 2021-02-27

药物性肝损伤基层诊疗指南（实践版·2019）

中华医学会(CMA,Chinese Medical Association) · 2020-10-19

药物性肝损伤基层诊疗指南（2019年）

中华医学会(CMA,Chinese Medical Association) · 2020-10-20

2019 EASL临床实践指南：药物性肝损伤

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2019-03-26

2016 血液病患者药物性肝损伤的预防和规范化治疗专家共识（2016年版）

中国临床肿瘤学会(CSCO,Chinese Society of Clinical Oncology) · 2016-06-30

药物性肝损伤诊断的因果评分系统

暂未更新 · 2016-06-08

拓展阅读

2014 ACG 药物性肝损伤诊断和管理临床指南

美国胃肠病学院(ACG,American College of Gastroenterology) · 2014-06-17

药物性肝损伤诊治指南2015版

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-06-02

药物性肝损伤诊断的因果评分系统

暂未更新 · 2016-06-08

2016 血液病患者药物性肝损伤的预防和规范化治疗专家共识（2016年版）

中国临床肿瘤学会(CSCO,Chinese Society of Clinical Oncology) · 2016-06-30

2019 EASL临床实践指南：药物性肝损伤

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2019-03-26

药物性肝损伤基层诊疗指南（2019年）

中华医学会(CMA,Chinese Medical Association) · 2020-10-20